cGxP.wire https://validator.w3.org/feed/docs/rss2.html AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers Evommune Launches Phase 2b Trial of EVO756 for Migraine Prevention 60 Degrees Pharmaceuticals Reaches Babesiosis Study Enrollment Milestone Hyperfine Expands Clinical Evidence for Swoop Portable MRI MMI Advances REMIND Alzheimer’s Study After FDA IDE Approval Savara Secures European, Australian Patents for MOLBREEVI Through 2041 Lupin Boosts U.S. Generics Business with FDA Approval Caldera, Synlogic Unite in $278M Biotech Merger Sumitomo Pharma’s Enzomenib Gains FDA Orphan Drug Status for ALL Latigo Biotherapeutics Reports NEJM-Published Positive LTG-001 Acute Pain Trial Results AB2 Bio Lands $30M U.S. Deal for Tadekinig Alfa Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo Smith+Nephew Sets New Standard in Sports Medicine AI Verdiva Bio Starts Phase 1 Trial of Weekly Oral VRB-103 Biocon Secures Health Canada Approval for Yesintek Pen IceCure Seeks NCCN Support for Breast Cancer Cryoablation Mesoblast Strengthens Cell Therapy Portfolio with RYONCIL Growth and FDA Progress Corbus Moves CRB-701 Toward FDA Registration Allogene Therapeutics Receives FDA RMAT Status for Cema-Cel Pfizer’s PREVNAR 20 Selected for Québec Pediatric Program ImmunityBio Receives UAE Marketing Authorization for ANKTIVA VB Spine Receives FDA Clearance for Expanded Vitoss Indications CalciMedica Aligns With FDA on Auxora Phase 2b Trial Viatris Wins U.S. FDA Approval for Gwyn Lo Contraceptive Iksuda Therapeutics Secures FDA IND Clearance for IKS04 FlyteHealth Expands Medicare Care Through CMS Platform Aqua Medical Treats First U.S. Patient in Diabetes Trial Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine Seegene Expands Precision Diagnostics for Women’s Health AbbVie Secures EU Approval for RINVOQ in Severe Alopecia Areata Evinova and Merck KGaA Partner to Advance AI Clinical Development Alamar Biosciences Launches NULISAseq Immune 340 Panel AGC Biologics Strengthens Global CDMO Leadership MannKind Reports Positive Phase 1b INFLO-1 IPF Results AbbVie Gains EU Approval for RINVOQ in Vitiligo Care NeuroPace Receives FDA Feedback on IGE PMA Supplement Saol Therapeutics Advances SL1009 in FDA Review Verastem Oncology Doses First Patient in TARGET-D 203 Trial GSK Invests £400M in Cambridge R&D Innovation Centre Knack RCM Unveils AI-Native Anesthesia Revenue Cycle Platform Ambrosia Expands Scientific Leadership in Metabolic Disease Incyte Secures EU Approval for Opzelura Cream in Atopic Dermatitis GSK Accelerates R&D After Strong Q2 2026 Performance Eisai Grants CORE Exclusive Global Oncology Rights Cipla Receives FDA Nod for Generic Advair Diskus United Therapeutics Reports Phase 3 Ralinepag Results in The Lancet TScan Therapeutics Doses First Patient in Phase 3 ALLOHA-2 Trial CORE Biomedicine Secures $21M Series A Funding Firefly Bio Acquisition Strengthens J&J Cancer Portfolio Elevation Spine Secures FDA Clearance for Saber-C AVIA